机构:
Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA
Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USABeth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA
Julg, Boris
[1
,2
]
Barouch, Dan H.
论文数: 0引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA
Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USABeth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA
Barouch, Dan H.
[1
,2
]
机构:
[1] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA
[2] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA
The latent HIV-1 reservoir represents the major barrier for the development of an HIV-1 cure. In this issue of Immunity, Shan et al. (2017) highlight that effector-to-memory transitioning (EMT) CD4(+) T cells are particularly permissive for the establishment of latent HIV-1 infection.
机构:
Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USAUniv Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
Ruelas, Debbie S.
Greene, Warner C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA
Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USAUniv Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA